Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases

Conditions:   Rheumatoid Arthritis;   Ankylosing Spondylitis;   Systemic Lupus Erythematosus;   Psoriasis;   Behcet's Disease;   Wegener's Granulomatosis;   Takayasu's Disease;   Crohn's Disease;   Ulcerative Colitis;   Autoimmune Hepatitis;   Sclerosing CholangitisIntervention:   Drug: Interleukin 2Sponsors:   Assistance Publique - Hôpitaux de Paris;   ILTOO PharmaNot yet recruiting - verified November 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials